The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.10te% Regulatory News (SAN)

Share Price Information for Sant Uk.10te% (SAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 147.75
Bid: 145.50
Ask: 150.00
Change: 0.15 (0.10%)
Spread: 4.50 (3.093%)
Open: 147.60
High: 147.75
Low: 147.60
Prev. Close: 147.60
SAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Final Terms

2 Mar 2018 16:02

RNS Number : 5941G
Santander UK Plc
02 March 2018
 

 

SANTANDER UK PLC

€30 BILLION EURO MEDIUM TERM NOTE PROGRAMME

PUBLICATION OF FINAL TERMS - SERIES B-1481

 

The following final terms (the Final Terms) are available for viewing:

 

Issue of GBP 200,000,000 Floating Rate Senior Notes due 2020 (ISIN XS1785305779) (Series B-1481) (the Notes), under the €30 billion Euro Medium Term Note programme of Santander UK Group Holdings plc and Santander UK plc (the Programme).

 

To view the full Final Terms document, please click on or paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/5941G_-2018-3-2.pdf

 

A copy of the Final Terms has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do. This website is not provided for, nor is it directed at, U.S. persons or persons in the United States. If you are a U.S. person, or you are viewing this page from the United States, you should exit this section of the website.

 

For further information, please contact:

 

Medium Term Funding2 Triton SquareRegent's PlaceLondon NW1 3AN

 

Tel: +44 (0) 20 7756 7107

 

Email: mtf@santander.co.uk

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Final Terms and the base prospectus published in respect of the Programme on 30 August 2017, as supplemented on 14 September 2017, 26 October 2017 and 7 February 2018 (the Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries only (as further specified in the Prospectus) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and the Prospectus you must ascertain from the Final Terms and the Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon your compliance with the above requirement.

 

This publication of the Final Terms does not constitute an offer of securities for sale in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold in the United States of America or to, or for the benefit of, U.S. persons (as defined in Regulation S of the Securities Act), unless the securities are registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFTFKBDPPBKDCNK
Date   Source Headline
22nd Jan 20184:58 pmRNSArticle 8
22nd Jan 20183:02 pmRNS1119 ISE Delisting announcement
16th Jan 20184:45 pmRNSPublication of Final Terms
11th Jan 201812:04 pmRNSPublication of Final Terms
3rd Jan 201811:25 amRNSArticle 8
27th Dec 20172:25 pmRNSNotice of Early Redemption
21st Dec 20171:15 pmRNSDirectorate Change
14th Dec 20177:47 amRNSXS1656513832 - 1116 Delisting
12th Dec 20179:00 amRNSXS1656513832 - 1116 ISE Delisting
11th Dec 20175:34 pmRNSArticle 8
8th Dec 20178:03 amRNSArticle 8
27th Nov 20175:14 pmRNSNotice of Early Redemption
27th Nov 201711:06 amRNSDirectorate Change
17th Nov 20174:23 pmRNSPublication of Final Terms
26th Oct 20173:12 pmRNSPublication of Suppl.Prospcts
26th Oct 20173:10 pmRNSPublication of Suppl.Prospcts
26th Oct 20177:15 amRNS3rd Quarter Results
23rd Oct 201712:03 pmRNSDelisting
16th Oct 20175:51 pmRNSNotice of Substitution of Issuer
16th Oct 20175:47 pmRNSNotice of Substitution of Issuer
16th Oct 20175:46 pmRNSNotice of Substitution of Issuer
16th Oct 20171:09 pmRNSRing-Fencing Update
13th Oct 20173:46 pmRNSPublication of Final Terms
27th Sep 20171:07 pmRNSPublication of Final Terms
20th Sep 201712:51 pmRNSPublication of Final Terms
19th Sep 20174:25 pmRNSPurchase & Cancellation of Notes
14th Sep 20176:32 pmRNSPublication of Suppl.Prospcts
14th Sep 20176:28 pmRNSPublication of Suppl.Prospcts
14th Sep 20177:15 amRNSHalf-year Report
14th Sep 20177:15 amRNSHalf-year Report
12th Sep 201711:53 amRNSNotice of Delisting XS1606968771
1st Sep 20173:10 pmRNSPublication of Final Terms
31st Aug 20177:00 amRNSPublication of a Prospectus
31st Aug 20177:00 amRNSPublication of a Prospectus
28th Jul 20174:52 pmRNSGlobal Covered Bond Programme Supplement
28th Jul 20174:50 pmRNSMedium Term Note Programme Supplement
28th Jul 20177:15 amRNSQMS for 6 months ending 30 June 2017
14th Jul 20172:05 pmRNSNotice of Delisting
2nd Jun 20175:47 pmRNSPublication of a Prospectus
22nd May 201710:52 amRNSDirectorate Change
19th May 20172:12 pmRNSNotice of Delisting XS1561800175
18th May 201711:02 amRNSPublication of Final Terms
4th May 20174:17 pmRNSPublication of Final Terms
26th Apr 20176:27 pmRNSPublication of Suppl.Prospcts
26th Apr 20175:58 pmRNSPublication of Suppl.Prospcts
26th Apr 20177:30 amRNS1st Quarter Results
6th Apr 20176:30 pmRNSPublication of a Prospectus
31st Mar 20172:45 pmRNSResult of AGM
10th Mar 201711:56 amRNSPublication of Final Terms
23rd Feb 20175:40 pmRNSPublication of Suppl.Prospcts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.